甘草酸二铵治疗各类肝病629例临床观察

Clinical research on treatment on several kinds of liver hepatitis with diammonium glycyrrhizinate

目的 回顾性观察甘草酸二铵注射液在慢性肝炎、肝炎肝硬化、药物性肝炎和酒精性肝炎治疗中消炎降酶的作用。方法 甘草酸二铵注射液 15 0mg ,加入 5 %～ 10 %葡萄糖注射液 2 5 0ml中静脉点滴 ,治疗轻～中度慢性肝炎、肝炎肝硬化、药物性肝炎和酒精性肝炎共 6 2 9例 ,强力宁注射液(10 0ml/d)治疗慢性肝炎 12 7例作为对照 ,治疗结束后进行疗效分析。结果 两组患者症状、体征的恢复无明显差异 ,但丙氨酸氨基转移酶 (ALT)、血清胆红素 (SB)的恢复速度治疗组明显优于对照组。在治疗 17d时治疗组有 93.3%患者的ALT恢复正常 ,而对照组为 73.3% ,两组差异有显著性 (P <0 .0 5 )。在治疗 10d时治疗组有 86 .7%患者的SB恢复正常 ,而对照组仅为 4 0 % ,两组有显著差异 (P<0 .0 1)。在治疗 17d时治疗组和对照组的血清白蛋白含量分别为 (4 4 .7± 5 .6 7) g/L和 (4 5 .2±5 .5 6 ) g/L ,两组差异无显著性 (P <0 .0 5 )。在本研究中 ,甘草酸二铵治疗组未发生明显的不良反应。结论 甘草酸二铵可明显改善病毒性、药物性、酒精性等肝脏急性或慢性炎症的临床症状和肝功能指标 ,在慢性肝炎组中 。

Objective Retrospective observating the diminishing inflammation and lowering enzymatic effect with diammonium glycyrrhizinate (ganlixin injectionfluid) on hepatitis, such as chronic hepatitis, hepatocirrhosis, drug induced hepatitis and alcoholic hepatitis. Methods The 629 case hepatitis sufferers, including chronic hepatitis with light to middle degree, hepatocirrhosis, drug induced hepatitis and alcoholic hepatitis, were treated with 150 mg diammonium glycyrrhizinate added into 250 ml 5 % to 10 % glucose injection liquid. Another 127 chronic hepatitis sufferers treated with injecho potenl ini were seen as contrast. When the treatment was over, the level of alanine aminotransferase (ALT) and serum bilirubin (SB) and symptom of patients in two groups were analysed. Results The level of ALT and SB dropped more rapidly than that in contrast group, but there were no marked difference in symptoms recover. After 17 days therapy, there are 93.3 % patients with ALT normal level in treating group, but 73.3% in contrast group (P<0.05). At day 10, the patient recover normal SB were 86.7% in treating group, but that was 40% in contrast group (P<0.01). Level of SB has no marked difference in two groups, and there were no obvious bad reaction in diammonium glycyrrhizinate group. Conclusions Clinic symptom and liver function index can be improved after treatment with Ganlixin injection fluid in acute or chronic hepatitis sufferers, included virus, drug induced and alcoholic hepatitis. At the same time, it can better improve hepatitis sufferers' symptom and liver functions than injecho potenlini in the group of chronic hepatitis.